全球个性化医学诊断市场(2012-2016年)
Personalized medicine is a field of medicine that involves the modification of medical and diagnostic treatments to treat any patient, depending on the biological characteristics of the patient. Personalized medicine may be referred to as an extension of conventional methods of consideration and treatment of various diseases. Genetic information of the patient plays an important role in this field of the Healthcare industry. Moreover, the advantage of customization of healthcare treatments can be achieved via personalized medicines, drugs, services, and technologies. The Global Personalized Medicine Diagnostics market is expected to grow at a rapid pace during the period 2012-2016. The Americas generates the highest revenue in the Global Personalized Medicine Diagnostics market, and it is followed by the EMEA region. Although the APAC region currently holds the least market share, certain countries in the APAC region, such as Japan, India, and China offer significant growth opportunities. Moreover, there is a substantial demand for healthcare facilities, personalized medicine diagnostics, and treatments in China and India as these are the most populated countries in the world and thus have a large number of patients. Further, the rapid growth of the market in developing countries is expected to lead to an increase in research on personalized medicine diagnostics.